Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities    
Net loss $ (12,474) $ (19,474)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities    
Depreciation and amortization 37,947 38,884
Amortization of deferred financing costs 1,569 1,584
Deferred income taxes (8,197) (6,087)
Non-cash foreign currency loss (gain) (163) (1,356)
Share-based compensation 4,564 846
Provision for doubtful accounts 117 888
Change in fair value of warrant liability (5,281) 3,482
Change in operating assets and liabilities, net of operating assets and liabilities acquired:    
Accounts receivable (12,792) (3,572)
Inventories (6,461) (2,668)
Prepaid expenses and other receivables (5,054) (2,485)
Accounts payable and accrued liabilities (2,366) 8,119
Deferred revenue (911) 307
Income taxes payable 63 225
Cash (used in) provided by operating activities (9,439) 18,693
Cash flows used in investing activities    
Additions to intangible assets (6,626) (8,224)
Additions to property and equipment (3,156) (1,450)
Acquisition of Integron LLC, net of cash acquired   366
Net cash used in investing activities (9,782) (9,308)
Cash flows from financing activities    
Proceeds from revolving credit facility 25,000 21,700
Repayments on revolving credit facility (25,000) (25,000)
Repayment of long-term debt (2,373) (2,436)
Proceeds from convertible debt 82,351  
Proceeds from equity portion of convertible debt, net of issuance costs 12,510  
Payment of deferred financing costs, relating to convertible debt (1,449)  
Repayment of related party note (1,538)  
Repurchase of common stock   (200)
Proceeds from CTAC and PIPE financing, net of issuance costs 223,001  
Settlement of preferred shares (229,915)  
Payment of capital lease obligations (815) (137)
Cash provided by (used in) financing activities 81,772 (6,073)
Effect of Exchange Rate Change on Cash and Cash Equivalents (188) (88)
Change in Cash and Cash Equivalents and Restricted Cash 62,363 3,224
Cash and Cash Equivalents and Restricted Cash, beginning of period 10,693 8,692
Cash and Cash Equivalents and Restricted Cash, end of period 73,056 11,916
Non-cash financing activities:    
Capital leases 346 263
Equity financing fees accrued 3,025  
Common shares issued to preferred shareholders 56,502  
Equity financing fees settled in common shares 1,863  
Common shares issued to warrant holders 10,663  
Supplemental cash flow information:    
Interest paid $ 14,762 $ 16,879